Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Applovin Corporation (APP) vs Summit Therapeutics Inc (SMMT) Price & Performance

Applovin CorporationTrade
Summit Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Applovin Corporation vs Summit Therapeutics Inc — how do they compare? Applovin Corporation trades at $319.52 (market cap $106.65B), while Summit Therapeutics Inc trades at $15.38 (market cap $12.06B). The key difference: Applovin Corporation is far larger — about 8.8× Summit Therapeutics Inc's market cap, and Summit Therapeutics Inc is trading nearer its 52-week high, Applovin Corporation nearer its low. Which is the better fit depends on your goals.

APPSMMT
Market Cap
$106.65B$12.06B
Sector
TechnologyHealth
52-Week High
$733.60$26.98
52-Week Low
$318.68$12.55
Enterprise Value
$107.11B$11.39B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Applovin Corporation

AppLovin provides a software platform for mobile app developers to market, monetize, and analyze their apps. Its AI-powered tools help developers grow their business by connecting them with global advertising networks.

Read more on APP

About Summit Therapeutics Inc

Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.

Read more on SMMT